TF and neoplasm: Tissue Factor (TF, CD142), expressed in extravascular cells (fibroblasts, smooth muscle), is implicated in tumor progression, therapy resistance, and enhanced pro-angiogenic signaling, with TF+ EVs fostering a pro-tumor microenvironment [69,70].